CHCO(CHCO)
CHCO
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $328M | $337M |
| Low | $326M | $335M |
| High | $329M | $338M |
| EBITDA Avg | $159M | $164M |
| Low | $159M | $163M |
| High | $160M | $165M |
| EBIT Avg | $145M | $149M |
| Low | $145M | $148M |
| High | $146M | $150M |
| Net Income Avg | $133M | $138M |
| Low | $132M | $136M |
| High | $134M | $139M |
| EPS Avg | $9.26 | $9.58 |
| Low | $9.20 | $9.44 |
| High | $9.32 | $9.71 |
| Analysts (Rev / EPS) | 2 / 4 | 2 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $83M | $84M | $82M | $84M | $85M | $86M |
| Low | $82M | $83M | $82M | $83M | $84M | $85M |
| High | $83M | $84M | $83M | $84M | $85M | $86M |
| EBITDA Avg | $40M | $41M | $40M | $41M | $41M | $42M |
| Low | $40M | $40M | $40M | $40M | $41M | $41M |
| High | $41M | $41M | $40M | $41M | $42M | $42M |
| EBIT Avg | $37M | $37M | $36M | $37M | $38M | $38M |
| Low | $37M | $37M | $36M | $37M | $37M | $38M |
| High | $37M | $37M | $37M | $37M | $38M | $38M |
| Net Income Avg | $33M | $33M | $32M | $33M | $34M | $35M |
| Low | $33M | $33M | $32M | $33M | $34M | $34M |
| High | $33M | $34M | $32M | $34M | $35M | $35M |
| EPS Avg | $2.35 | $2.36 | $2.29 | $2.38 | $2.45 | $2.46 |
| Low | $2.32 | $2.33 | $2.26 | $2.36 | $2.42 | $2.44 |
| High | $2.37 | $2.39 | $2.31 | $2.40 | $2.47 | $2.48 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |